APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mefenamic Acid

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mefenamic Acid Market Outlook and Growth Opportunities 2026

19 December 2025216 pages

Choose your research edition.

Industry ResearchMefenamic Acid Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Mefenamic Acid Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Mefenamic Acid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mefenamic Acid Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Mefenamic Acid Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Mefenamic Acid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mefenamic Acid market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mefenamic Acid market include AA Pharma, ABL Lifecare, Adelco, Agron Remedies, Apotex, Captab, Chemidex Pharma, Daiichi Sankyo and EMS Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mefenamic Acid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mefenamic Acid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mefenamic Acid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mefenamic Acid market size, projected growth trends, production technologies, key applications, and end-use industries.

Mefenamic Acid Segment by Company

AA Pharma

ABL Lifecare

Adelco

Agron Remedies

Apotex

Captab

Chemidex Pharma

Daiichi Sankyo

EMS Pharma

Esteve

Farmo Quimica

IASIS Pharmaceuticals Hellas

Koa Isei

Mankind

Nisshin Pharmaceutical

Sanofi Aventis

Shinto Organics

Shionogi Pharma

Solitaire Pharmacia

Streuli Pharma,

Wockhardt

Yung Sine

Pfizer

Teva

Mefenamic Acid Segment by Type

Patent

Generic

Mefenamic Acid Segment by Application

On-line

Drug Store

Hospital

Mefenamic Acid Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Mefenamic Acid status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mefenamic Acid market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mefenamic Acid significant trends, drivers, influence factors in global and regions.

6. To analyze Mefenamic Acid competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mefenamic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mefenamic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mefenamic Acid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mefenamic Acid market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mefenamic Acid industry.

Chapter 3: Detailed analysis of Mefenamic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mefenamic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mefenamic Acid in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mefenamic Acid Industry Trends Table 2. Mefenamic Acid Industry Drivers Table 3. Mefenamic Acid Industry Opportunities and Challenges Table 4. Mefenamic Acid Industry Restraints Table 5. Global Mefenamic Acid Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mefenamic Acid Revenue Share by Company (2021-2026) Table 7. Global Mefenamic Acid Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Mefenamic Acid Sales Volume Share by Company (2021-2026) Table 9. Global Mefenamic Acid Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Mefenamic Acid Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mefenamic Acid Key Company Manufacturing Base & Headquarters Table 12. Global Mefenamic Acid Company, Product Type & Application Table 13. Global Mefenamic Acid Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mefenamic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Patent Table 18. Significant Companies of Generic Table 19. Global Mefenamic Acid Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Mefenamic Acid Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Mefenamic Acid Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Mefenamic Acid Sales Volume Share by Type (2021-2026) Table 23. Global Mefenamic Acid Sales Volume Share by Type (2027-2032) Table 24. Global Mefenamic Acid Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Mefenamic Acid Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Mefenamic Acid Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Mefenamic Acid Sales Value Share by Type (2021-2026) Table 28. Global Mefenamic Acid Sales Value Share by Type (2027-2032) Table 29. Significant Companies of On-line Table 30. Significant Companies of Drug Store Table 31. Significant Companies of Hospital Table 32. Global Mefenamic Acid Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Mefenamic Acid Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Mefenamic Acid Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Mefenamic Acid Sales Volume Share by Application (2021-2026) Table 36. Global Mefenamic Acid Sales Volume Share by Application (2027-2032) Table 37. Global Mefenamic Acid Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Mefenamic Acid Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Mefenamic Acid Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Mefenamic Acid Sales Value Share by Application (2021-2026) Table 41. Global Mefenamic Acid Sales Value Share by Application (2027-2032) Table 42. Global Mefenamic Acid Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Mefenamic Acid Sales by Region (2021-2026) & (K Units) Table 44. Global Mefenamic Acid Sales Market Share by Region (2021-2026) Table 45. Global Mefenamic Acid Sales by Region (2027-2032) & (K Units) Table 46. Global Mefenamic Acid Sales Market Share by Region (2027-2032) Table 47. Global Mefenamic Acid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Mefenamic Acid Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Mefenamic Acid Sales Value Share by Region (2021-2026) Table 50. Global Mefenamic Acid Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Mefenamic Acid Sales Value Share by Region (2027-2032) Table 52. Global Mefenamic Acid Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Mefenamic Acid Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Mefenamic Acid Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Mefenamic Acid Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 57. Global Mefenamic Acid Sales Market Share by Country (2021-2026) Table 58. Global Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 59. Global Mefenamic Acid Sales Market Share by Country (2027-2032) Table 60. Global Mefenamic Acid Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Mefenamic Acid Sales Value Market Share by Country (2021-2026) Table 62. Global Mefenamic Acid Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Mefenamic Acid Sales Value Market Share by Country (2027-2032) Table 64. AA Pharma Company Information Table 65. AA Pharma Business Overview Table 66. AA Pharma Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. AA Pharma Mefenamic Acid Product Portfolio Table 68. AA Pharma Recent Development Table 69. ABL Lifecare Company Information Table 70. ABL Lifecare Business Overview Table 71. ABL Lifecare Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. ABL Lifecare Mefenamic Acid Product Portfolio Table 73. ABL Lifecare Recent Development Table 74. Adelco Company Information Table 75. Adelco Business Overview Table 76. Adelco Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Adelco Mefenamic Acid Product Portfolio Table 78. Adelco Recent Development Table 79. Agron Remedies Company Information Table 80. Agron Remedies Business Overview Table 81. Agron Remedies Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Agron Remedies Mefenamic Acid Product Portfolio Table 83. Agron Remedies Recent Development Table 84. Apotex Company Information Table 85. Apotex Business Overview Table 86. Apotex Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Apotex Mefenamic Acid Product Portfolio Table 88. Apotex Recent Development Table 89. Captab Company Information Table 90. Captab Business Overview Table 91. Captab Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Captab Mefenamic Acid Product Portfolio Table 93. Captab Recent Development Table 94. Chemidex Pharma Company Information Table 95. Chemidex Pharma Business Overview Table 96. Chemidex Pharma Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Chemidex Pharma Mefenamic Acid Product Portfolio Table 98. Chemidex Pharma Recent Development Table 99. Daiichi Sankyo Company Information Table 100. Daiichi Sankyo Business Overview Table 101. Daiichi Sankyo Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Daiichi Sankyo Mefenamic Acid Product Portfolio Table 103. Daiichi Sankyo Recent Development Table 104. EMS Pharma Company Information Table 105. EMS Pharma Business Overview Table 106. EMS Pharma Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. EMS Pharma Mefenamic Acid Product Portfolio Table 108. EMS Pharma Recent Development Table 109. Esteve Company Information Table 110. Esteve Business Overview Table 111. Esteve Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Esteve Mefenamic Acid Product Portfolio Table 113. Esteve Recent Development Table 114. Farmo Quimica Company Information Table 115. Farmo Quimica Business Overview Table 116. Farmo Quimica Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Farmo Quimica Mefenamic Acid Product Portfolio Table 118. Farmo Quimica Recent Development Table 119. IASIS Pharmaceuticals Hellas Company Information Table 120. IASIS Pharmaceuticals Hellas Business Overview Table 121. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio Table 123. IASIS Pharmaceuticals Hellas Recent Development Table 124. Koa Isei Company Information Table 125. Koa Isei Business Overview Table 126. Koa Isei Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Koa Isei Mefenamic Acid Product Portfolio Table 128. Koa Isei Recent Development Table 129. Mankind Company Information Table 130. Mankind Business Overview Table 131. Mankind Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Mankind Mefenamic Acid Product Portfolio Table 133. Mankind Recent Development Table 134. Nisshin Pharmaceutical Company Information Table 135. Nisshin Pharmaceutical Business Overview Table 136. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Nisshin Pharmaceutical Mefenamic Acid Product Portfolio Table 138. Nisshin Pharmaceutical Recent Development Table 139. Sanofi Aventis Company Information Table 140. Sanofi Aventis Business Overview Table 141. Sanofi Aventis Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Sanofi Aventis Mefenamic Acid Product Portfolio Table 143. Sanofi Aventis Recent Development Table 144. Shinto Organics Company Information Table 145. Shinto Organics Business Overview Table 146. Shinto Organics Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Shinto Organics Mefenamic Acid Product Portfolio Table 148. Shinto Organics Recent Development Table 149. Shionogi Pharma Company Information Table 150. Shionogi Pharma Business Overview Table 151. Shionogi Pharma Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Shionogi Pharma Mefenamic Acid Product Portfolio Table 153. Shionogi Pharma Recent Development Table 154. Solitaire Pharmacia Company Information Table 155. Solitaire Pharmacia Business Overview Table 156. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Solitaire Pharmacia Mefenamic Acid Product Portfolio Table 158. Solitaire Pharmacia Recent Development Table 159. Streuli Pharma, Company Information Table 160. Streuli Pharma, Business Overview Table 161. Streuli Pharma, Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Streuli Pharma, Mefenamic Acid Product Portfolio Table 163. Streuli Pharma, Recent Development Table 164. Wockhardt Company Information Table 165. Wockhardt Business Overview Table 166. Wockhardt Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Wockhardt Mefenamic Acid Product Portfolio Table 168. Wockhardt Recent Development Table 169. Yung Sine Company Information Table 170. Yung Sine Business Overview Table 171. Yung Sine Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Yung Sine Mefenamic Acid Product Portfolio Table 173. Yung Sine Recent Development Table 174. Pfizer Company Information Table 175. Pfizer Business Overview Table 176. Pfizer Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Pfizer Mefenamic Acid Product Portfolio Table 178. Pfizer Recent Development Table 179. Teva Company Information Table 180. Teva Business Overview Table 181. Teva Mefenamic Acid Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Teva Mefenamic Acid Product Portfolio Table 183. Teva Recent Development Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Mefenamic Acid Distributors List Table 187. Mefenamic Acid Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Mefenamic Acid Product Image Figure 2. Global Mefenamic Acid Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mefenamic Acid Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mefenamic Acid Sales (2021-2032) & (K Units) Figure 5. Global Mefenamic Acid Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Mefenamic Acid Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Patent Image Figure 10. Generic Image Figure 11. Global Mefenamic Acid Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Mefenamic Acid Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Mefenamic Acid Sales Volume Share by Type (2021-2032) Figure 14. Global Mefenamic Acid Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Mefenamic Acid Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Mefenamic Acid Sales Value Share by Type (2021-2032) Figure 17. On-line Image Figure 18. Drug Store Image Figure 19. Hospital Image Figure 20. Global Mefenamic Acid Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Mefenamic Acid Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Mefenamic Acid Sales Volume Share by Application (2021-2032) Figure 23. Global Mefenamic Acid Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Mefenamic Acid Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Mefenamic Acid Sales Value Share by Application (2021-2032) Figure 26. Global Mefenamic Acid Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Mefenamic Acid Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Mefenamic Acid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Mefenamic Acid Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Mefenamic Acid Sales Value (2021-2032) & (US$ Million) Figure 31. North America Mefenamic Acid Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Mefenamic Acid Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Mefenamic Acid Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Mefenamic Acid Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Mefenamic Acid Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Mefenamic Acid Sales Value (2021-2032) & (US$ Million) Figure 37. South America Mefenamic Acid Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Mefenamic Acid Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Mefenamic Acid Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Mefenamic Acid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Mefenamic Acid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Mefenamic Acid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Mefenamic Acid Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Mefenamic Acid Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • On-line
  • Drug Store
  • Hospital
Companies covered
  • AA Pharma
  • ABL Lifecare
  • Adelco
  • Agron Remedies
  • Apotex
  • Captab
  • Chemidex Pharma
  • Daiichi Sankyo
  • EMS Pharma
  • Esteve
  • Farmo Quimica
  • IASIS Pharmaceuticals Hellas
  • Koa Isei
  • Mankind
  • Nisshin Pharmaceutical
  • Sanofi Aventis
  • Shinto Organics
  • Shionogi Pharma
  • Solitaire Pharmacia
  • Streuli Pharma,
  • Wockhardt
  • Yung Sine
  • Pfizer
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mefenamic Acid Sales Value (2021-2032)
  4. 1.2.2 Global Mefenamic Acid Sales Volume (2021-2032)
  5. 1.2.3 Global Mefenamic Acid Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mefenamic Acid Market Dynamics
  1. 2.1 Mefenamic Acid Industry Trends
  2. 2.2 Mefenamic Acid Industry Drivers
  3. 2.3 Mefenamic Acid Industry Opportunities and Challenges
  4. 2.4 Mefenamic Acid Industry Restraints
3 Mefenamic Acid Market by Company
  1. 3.1 Global Mefenamic Acid Company Revenue Ranking in 2025
  2. 3.2 Global Mefenamic Acid Revenue by Company (2021-2026)
  3. 3.3 Global Mefenamic Acid Sales Volume by Company (2021-2026)
  4. 3.4 Global Mefenamic Acid Average Price by Company (2021-2026)
  5. 3.5 Global Mefenamic Acid Company Ranking (2024-2026)
  6. 3.6 Global Mefenamic Acid Company Manufacturing Base and Headquarters
  7. 3.7 Global Mefenamic Acid Company Product Type and Application
  8. 3.8 Global Mefenamic Acid Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mefenamic Acid Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mefenamic Acid Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mefenamic Acid Market by Type
  1. 4.1 Mefenamic Acid Type Introduction
  2. 4.1.1 Patent
  3. 4.1.2 Generic
  4. 4.2 Global Mefenamic Acid Sales Volume by Type
  5. 4.2.1 Global Mefenamic Acid Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mefenamic Acid Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Mefenamic Acid Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Mefenamic Acid Sales Value by Type
  9. 4.3.1 Global Mefenamic Acid Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mefenamic Acid Sales Value by Type (2021-2032)
  11. 4.3.3 Global Mefenamic Acid Sales Value Share by Type (2021-2032)
5 Mefenamic Acid Market by Application
  1. 5.1 Mefenamic Acid Application Introduction
  2. 5.1.1 On-line
  3. 5.1.2 Drug Store
  4. 5.1.3 Hospital
  5. 5.2 Global Mefenamic Acid Sales Volume by Application
  6. 5.2.1 Global Mefenamic Acid Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mefenamic Acid Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Mefenamic Acid Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Mefenamic Acid Sales Value by Application
  10. 5.3.1 Global Mefenamic Acid Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mefenamic Acid Sales Value by Application (2021-2032)
  12. 5.3.3 Global Mefenamic Acid Sales Value Share by Application (2021-2032)
6 Mefenamic Acid Regional Sales and Value Analysis
  1. 6.1 Global Mefenamic Acid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mefenamic Acid Sales by Region (2021-2032)
  3. 6.2.1 Global Mefenamic Acid Sales by Region: 2021-2026
  4. 6.2.2 Global Mefenamic Acid Sales by Region (2027-2032)
  5. 6.3 Global Mefenamic Acid Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mefenamic Acid Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mefenamic Acid Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mefenamic Acid Sales Value by Region (2027-2032)
  9. 6.5 Global Mefenamic Acid Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mefenamic Acid Sales Value (2021-2032)
  12. 6.6.2 North America Mefenamic Acid Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mefenamic Acid Sales Value (2021-2032)
  15. 6.7.2 Europe Mefenamic Acid Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mefenamic Acid Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mefenamic Acid Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mefenamic Acid Sales Value (2021-2032)
  21. 6.9.2 South America Mefenamic Acid Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mefenamic Acid Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mefenamic Acid Sales Value Share by Country, 2025 VS 2032
7 Mefenamic Acid Country-level Sales and Value Analysis
  1. 7.1 Global Mefenamic Acid Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mefenamic Acid Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mefenamic Acid Sales by Country (2021-2032)
  4. 7.3.1 Global Mefenamic Acid Sales by Country (2021-2026)
  5. 7.3.2 Global Mefenamic Acid Sales by Country (2027-2032)
  6. 7.4 Global Mefenamic Acid Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mefenamic Acid Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mefenamic Acid Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mefenamic Acid Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mefenamic Acid Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mefenamic Acid Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mefenamic Acid Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mefenamic Acid Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mefenamic Acid Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mefenamic Acid Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mefenamic Acid Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mefenamic Acid Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mefenamic Acid Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mefenamic Acid Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mefenamic Acid Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mefenamic Acid Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mefenamic Acid Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mefenamic Acid Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mefenamic Acid Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mefenamic Acid Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mefenamic Acid Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mefenamic Acid Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mefenamic Acid Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mefenamic Acid Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mefenamic Acid Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mefenamic Acid Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mefenamic Acid Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mefenamic Acid Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mefenamic Acid Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mefenamic Acid Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mefenamic Acid Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mefenamic Acid Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mefenamic Acid Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AA Pharma
  2. 8.1.1 AA Pharma Company Information
  3. 8.1.2 AA Pharma Business Overview
  4. 8.1.3 AA Pharma Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AA Pharma Mefenamic Acid Product Portfolio
  6. 8.1.5 AA Pharma Recent Developments
  7. 8.2 ABL Lifecare
  8. 8.2.1 ABL Lifecare Company Information
  9. 8.2.2 ABL Lifecare Business Overview
  10. 8.2.3 ABL Lifecare Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ABL Lifecare Mefenamic Acid Product Portfolio
  12. 8.2.5 ABL Lifecare Recent Developments
  13. 8.3 Adelco
  14. 8.3.1 Adelco Company Information
  15. 8.3.2 Adelco Business Overview
  16. 8.3.3 Adelco Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Adelco Mefenamic Acid Product Portfolio
  18. 8.3.5 Adelco Recent Developments
  19. 8.4 Agron Remedies
  20. 8.4.1 Agron Remedies Company Information
  21. 8.4.2 Agron Remedies Business Overview
  22. 8.4.3 Agron Remedies Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Agron Remedies Mefenamic Acid Product Portfolio
  24. 8.4.5 Agron Remedies Recent Developments
  25. 8.5 Apotex
  26. 8.5.1 Apotex Company Information
  27. 8.5.2 Apotex Business Overview
  28. 8.5.3 Apotex Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Apotex Mefenamic Acid Product Portfolio
  30. 8.5.5 Apotex Recent Developments
  31. 8.6 Captab
  32. 8.6.1 Captab Company Information
  33. 8.6.2 Captab Business Overview
  34. 8.6.3 Captab Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Captab Mefenamic Acid Product Portfolio
  36. 8.6.5 Captab Recent Developments
  37. 8.7 Chemidex Pharma
  38. 8.7.1 Chemidex Pharma Company Information
  39. 8.7.2 Chemidex Pharma Business Overview
  40. 8.7.3 Chemidex Pharma Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Chemidex Pharma Mefenamic Acid Product Portfolio
  42. 8.7.5 Chemidex Pharma Recent Developments
  43. 8.8 Daiichi Sankyo
  44. 8.8.1 Daiichi Sankyo Company Information
  45. 8.8.2 Daiichi Sankyo Business Overview
  46. 8.8.3 Daiichi Sankyo Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Daiichi Sankyo Mefenamic Acid Product Portfolio
  48. 8.8.5 Daiichi Sankyo Recent Developments
  49. 8.9 EMS Pharma
  50. 8.9.1 EMS Pharma Company Information
  51. 8.9.2 EMS Pharma Business Overview
  52. 8.9.3 EMS Pharma Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 EMS Pharma Mefenamic Acid Product Portfolio
  54. 8.9.5 EMS Pharma Recent Developments
  55. 8.10 Esteve
  56. 8.10.1 Esteve Company Information
  57. 8.10.2 Esteve Business Overview
  58. 8.10.3 Esteve Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Esteve Mefenamic Acid Product Portfolio
  60. 8.10.5 Esteve Recent Developments
  61. 8.11 Farmo Quimica
  62. 8.11.1 Farmo Quimica Company Information
  63. 8.11.2 Farmo Quimica Business Overview
  64. 8.11.3 Farmo Quimica Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Farmo Quimica Mefenamic Acid Product Portfolio
  66. 8.11.5 Farmo Quimica Recent Developments
  67. 8.12 IASIS Pharmaceuticals Hellas
  68. 8.12.1 IASIS Pharmaceuticals Hellas Company Information
  69. 8.12.2 IASIS Pharmaceuticals Hellas Business Overview
  70. 8.12.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio
  72. 8.12.5 IASIS Pharmaceuticals Hellas Recent Developments
  73. 8.13 Koa Isei
  74. 8.13.1 Koa Isei Company Information
  75. 8.13.2 Koa Isei Business Overview
  76. 8.13.3 Koa Isei Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Koa Isei Mefenamic Acid Product Portfolio
  78. 8.13.5 Koa Isei Recent Developments
  79. 8.14 Mankind
  80. 8.14.1 Mankind Company Information
  81. 8.14.2 Mankind Business Overview
  82. 8.14.3 Mankind Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Mankind Mefenamic Acid Product Portfolio
  84. 8.14.5 Mankind Recent Developments
  85. 8.15 Nisshin Pharmaceutical
  86. 8.15.1 Nisshin Pharmaceutical Company Information
  87. 8.15.2 Nisshin Pharmaceutical Business Overview
  88. 8.15.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Nisshin Pharmaceutical Mefenamic Acid Product Portfolio
  90. 8.15.5 Nisshin Pharmaceutical Recent Developments
  91. 8.16 Sanofi Aventis
  92. 8.16.1 Sanofi Aventis Company Information
  93. 8.16.2 Sanofi Aventis Business Overview
  94. 8.16.3 Sanofi Aventis Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Sanofi Aventis Mefenamic Acid Product Portfolio
  96. 8.16.5 Sanofi Aventis Recent Developments
  97. 8.17 Shinto Organics
  98. 8.17.1 Shinto Organics Company Information
  99. 8.17.2 Shinto Organics Business Overview
  100. 8.17.3 Shinto Organics Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Shinto Organics Mefenamic Acid Product Portfolio
  102. 8.17.5 Shinto Organics Recent Developments
  103. 8.18 Shionogi Pharma
  104. 8.18.1 Shionogi Pharma Company Information
  105. 8.18.2 Shionogi Pharma Business Overview
  106. 8.18.3 Shionogi Pharma Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Shionogi Pharma Mefenamic Acid Product Portfolio
  108. 8.18.5 Shionogi Pharma Recent Developments
  109. 8.19 Solitaire Pharmacia
  110. 8.19.1 Solitaire Pharmacia Company Information
  111. 8.19.2 Solitaire Pharmacia Business Overview
  112. 8.19.3 Solitaire Pharmacia Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Solitaire Pharmacia Mefenamic Acid Product Portfolio
  114. 8.19.5 Solitaire Pharmacia Recent Developments
  115. 8.20 Streuli Pharma,
  116. 8.20.1 Streuli Pharma, Company Information
  117. 8.20.2 Streuli Pharma, Business Overview
  118. 8.20.3 Streuli Pharma, Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Streuli Pharma, Mefenamic Acid Product Portfolio
  120. 8.20.5 Streuli Pharma, Recent Developments
  121. 8.21 Wockhardt
  122. 8.21.1 Wockhardt Company Information
  123. 8.21.2 Wockhardt Business Overview
  124. 8.21.3 Wockhardt Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Wockhardt Mefenamic Acid Product Portfolio
  126. 8.21.5 Wockhardt Recent Developments
  127. 8.22 Yung Sine
  128. 8.22.1 Yung Sine Company Information
  129. 8.22.2 Yung Sine Business Overview
  130. 8.22.3 Yung Sine Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Yung Sine Mefenamic Acid Product Portfolio
  132. 8.22.5 Yung Sine Recent Developments
  133. 8.23 Pfizer
  134. 8.23.1 Pfizer Company Information
  135. 8.23.2 Pfizer Business Overview
  136. 8.23.3 Pfizer Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Pfizer Mefenamic Acid Product Portfolio
  138. 8.23.5 Pfizer Recent Developments
  139. 8.24 Teva
  140. 8.24.1 Teva Company Information
  141. 8.24.2 Teva Business Overview
  142. 8.24.3 Teva Mefenamic Acid Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Teva Mefenamic Acid Product Portfolio
  144. 8.24.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mefenamic Acid Value Chain Analysis
  2. 9.1.1 Mefenamic Acid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mefenamic Acid Sales Mode & Process
  6. 9.2 Mefenamic Acid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mefenamic Acid Distributors
  9. 9.2.3 Mefenamic Acid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst